Consolidated Statements of Cash Flows

2011 Annual Report

Years Ended December 31,

(In millions)

2011

2010

2009

Operating activities

Net income

$2,646.7

$2,887.1

$4,745.9

Adjustments to reconcile net income to net cash

provided by operating activities:

Net realized gains/losses on investments

(235.1)

(194.1)

(56.4)

Other-than-temporary impairment losses recognized in income

93.3

39.4

450.2

Loss on disposal of assets

3.3

1.9

16.4

Gain on sale of business

(3,792.3)

Deferred income taxes

74.3

101.8

61.3

Amortization, net of accretion

541.5

497.7

446.4

Impairment of goodwill and other intangible assets

21.1

262.5

Depreciation expense

95.7

103.1

107.1

Impairment of property and equipment

95.3

Share-based compensation

134.8

136.0

153.6

Excess tax benefits from share-based compensation

(42.2)

(28.1)

(9.6)

Changes in operating assets and liabilities, net of

effect of business combinations:

Receivables, net

(401.8)

109.7

(484.2)

Other invested assets

(8.9)

5.1

(62.5)

Other assets

(259.2)

(320.1)

(119.3)

Policy liabilities

978.0

(330.7)

(748.2)

Unearned income

35.1

(158.6)

(27.3)

Accounts payable and accrued expenses

(208.7)

(58.2)

952.8

Other liabilities

(13.6)

(208.4)

(248.8)

Income taxes

(44.6)

(1,239.8)

1,391.4

Other, net

(14.2)

(43.5)

(0.1)

Net cash provided by operating activities

3,374.4

1,416.7

3,038.9

 

 

 

 

Investing activities

Purchases of fixed maturity securities

(11,914.8)

(10,567.2)

(7,186.8)

Proceeds from fixed maturity securities:

Sales

10,446.2

7,215.1

4,096.6

Maturities, calls and redemptions

1,891.3

3,321.7

1,551.7

Purchases of equity securities

(355.6)

(350.9)

(318.9)

Proceeds from sales of equity securities

287.4

197.9

577.3

Purchases of other invested assets

(207.9)

(91.4)

(49.0)

Proceeds from sales of other invested assets

29.4

34.5

3.5

Changes in securities lending collateral

28.9

(504.8)

132.4

Purchases of subsidiaries, net of cash acquired

(600.0)

(0.3)

(66.3)

Proceeds from sales of subsidiaries, net of cash sold

4,672.3

Purchases of property and equipment

(519.5)

(451.4)

(378.4)

Proceeds from sales of property and equipment

3.7

0.8

0.4

Other, net

(31.1)

(75.5)

(32.0)

Net cash (used in) provided by investing activities

(942.0)

(1,271.5)

3,002.8

 

 

 

 

Financing activities

Net proceeds from (repayments of) commercial paper borrowings

463.6

(164.4)

(397.0)

Proceeds from long-term borrowings

1,097.4

1,088.5

990.3

Repayments of long-term borrowings

(705.1)

(481.7)

(919.3)

Proceeds from short-term borrowings

100.0

100.0

Repayments of short-term borrowings

(100.0)

(98.0)

Changes in securities lending payable

(29.0)

504.9

(132.4)

Changes in bank overdrafts

264.3

(28.0)

(344.1)

Repurchase and retirement of common stock

(3,039.8)

(4,360.3)

(2,638.4)

Cash dividends

(357.8)

Proceeds from issuance of common stock under employee stock plans

245.0

143.6

126.5

Excess tax benefits from share-based compensation

42.2

28.1

9.6

Net cash used in financing activities

(2,019.2)

(3,169.3)

(3,402.8)

 

 

 

 

Effect of foreign exchange rates on cash and cash equivalents

(0.4)

(3.2)

(6.7)

Change in cash and cash equivalents

412.8

(3,027.3)

2,632.2

Cash and cash equivalents at beginning of period

1,788.8

4,816.1

2,183.9

 

 

 

 

Cash and cash equivalents at end of period

$2,201.6

$1,788.8

$4,816.1

The information presented above should be read in conjunction with the audited financial statements and accompanying notes included in WellPoint’s 2011 Annual Report on Form 10-K.